BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 13/03/2024

FDA Clears Path for Approval of Romidepsin Injection Formulations

The FDA has determined that two formulations of Romidepsin Injection were not withdrawn from sale due to safety or effectiveness concerns, allowing for the approval of abbreviated new drug applications for these formulations.

Source: Federal Register — Food and Drug AdministrationOpen original release →